Philippe L. Bédard

22.9k citations
347 papers · 9.7k indexed · 5 hit papers · h-index 50
Topics
Cancer Genomics and Diagnostics (96 papers)Testicular diseases and treatments (55 papers)Cancer Immunotherapy and Biomarkers (55 papers)
Partner nations
CanadaUnited StatesSpain

In The Last Decade

Philippe L. Bédard

329 papers receiving 9.6k citations

Hit Papers

Tumour heterogeneity in the clinic201320262017202120132020201820192021250500750

Peers

Philippe L. Bédard
Comparison fields: 5 of 151
  • Oncology 4.6k
  • Molecular Biology 3.2k
  • Cancer Research 2.9k
  • Pulmonary and Respiratory Medicine 2.3k
  • Surgery 1.2k
Replace Marcia S. Brose with:
Marcia S. Brose United States
Carey K. Anders United States
Alberto Ocaña Spain
Anthony Gonçalvès France
Fabio Puglisi Italy
Maura N. Dickler United States
Jennifer K. Litton United States
Massimo Gion Italy
George Somlo United States
Stephen Chan United Kingdom
Philippe L. Bédard relative to Marcia S. Brose United States Marcia S. Brose's profile →
Citations per field
00.5×1.5×2.4×
Marcia S. Brose · 1×
Citations per year

Countries citing papers authored by Philippe L. Bédard

Since Specialization
Citations

This map shows the geographic impact of Philippe L. Bédard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe L. Bédard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe L. Bédard more than expected).

Fields of papers citing papers by Philippe L. Bédard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe L. Bédard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe L. Bédard. The network helps show where Philippe L. Bédard may publish in the future.

Co-authorship network of co-authors of Philippe L. Bédard

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe L. Bédard. A scholar is included among the top collaborators of Philippe L. Bédard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe L. Bédard. Philippe L. Bédard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 1
4 1
5 9
6 9
7 20
8
Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumorsbreakdown →
257
9 9
10 9
11 1
12 57
13 28
14 8
15 22
16 59
17 75
18 257
19 67
20 278

About Philippe L. Bédard

Philippe L. Bédard is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 347 papers that have together received 9.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (96 papers), Testicular diseases and treatments (55 papers) and Cancer Immunotherapy and Biomarkers (55 papers). The work is most often cited by research in Cancer Research (2.9k citations), Oncology (4.6k citations) and Pulmonary and Respiratory Medicine (2.3k citations). Philippe L. Bédard has collaborated with scholars based in Canada, United States and Spain. Frequent co-authors include Lillian L. Siu, Aaron R. Hansen, Mark J. Ratain, Martine Piccart, David M. Hyman, Matthew S. Davids, Ben Tran, Janet Dancey, Eitan Amir and Nicole Onetto. Their work appears in journals such as Nature, Cell and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026